Manipulating the mTOR–SEMA6D–PPARγ axis, which connects macrophage immunological function and metabolism, offers promise in modulating immune responses and therapeutically influencing macrophage polarization not only in cancer but also in various other diseases. This evidence concerns the gene SEMA6D and cancer.